Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human CD338/ABCG2 Antibody (5D3)

Catalog #:   FHJ82310 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1, kappa
Applications: FCM
Accession: Q9UNQ0
Overview

Catalog No.

FHJ82310

Species reactivity

Human

Host species

Mouse

Isotype

IgG1, kappa

Clonality

Monoclonal

Conjugation

Unconjugated

Target

Urate exporter, ABCP, BCRP1, ABCG2, CD338, BCRP, MXR, Broad substrate specificity ATP-binding cassette transporter ABCG2, Placenta-specific ATP-binding cassette transporter, Breast cancer resistance protein, Mitoxantrone resistance-associated protein, CDw338, ATP-binding cassette sub-family G member 2

Concentration

1.83 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9UNQ0

Applications

FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

5D3

Data Image
  • Flow-cytometry
    Flow-cytometry using anti-human CD338 antibody.MCF7 cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human CD338 antibody monoclonal antibody (Catalog # FHJ82310 ,Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-mouse antibody (Catalog # PMB96441) and cells analysed on a NovoCyte Flow Cytometer.
References

Genotype Analysis of the JR Blood Group in an East Asian Population Using Tetra-Primer ARMS-PCR., PMID:39293835

Magnolol derivatives as specific and noncytotoxic inhibitors of breast cancer resistance protein (BCRP/ABCG2)., PMID:38513324

Tumor-acquired somatic mutation affects conformation to abolish ABCG2-mediated drug resistance., PMID:38387283

Structural Basis of the Allosteric Inhibition of Human ABCG2 by Nanobodies., PMID:37597690

Noninvasive Evaluation of Multidrug Resistance via Imaging of ABCG2/BCRP Multidrug Transporter in Lung Cancer Xenograft Models., PMID:35427142

A new porphyrin as selective substrate-based inhibitor of breast cancer resistance protein (BCRP/ABCG2)., PMID:34717915

Flavonoid Monomers as Potent, Nontoxic, and Selective Modulators of the Breast Cancer Resistance Protein (ABCG2)., PMID:34606270

Structures of ABCG2 under turnover conditions reveal a key step in the drug transport mechanism., PMID:34282134

Altered Profile of E1-S Transporters in Endometrial Cancer: Lower Protein Levels of ABCG2 and OSTβ and Up-Regulation of SLCO1B3 Expression., PMID:33917029

Calcium channel α2δ1 subunit is a functional marker and therapeutic target for tumor-initiating cells in non-small cell lung cancer., PMID:33707423

A Combined Bioinformatic and Nanoparticle-Based Study Reveal the Role of ABCG2 in the Drug Resistant Breast Cancer., PMID:33602075

Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indoles., PMID:33469044

The Role of Specific ATP-Binding Cassette Transporters in the Acquired Resistance to Pyrrolobenzodiazepine Dimer-Containing Antibody-Drug Conjugates., PMID:32669316

Mirror syndrome due to anti-Jra alloimmunization., PMID:32416899

[Isolation and Biological Characterization of Lung Cancer Stem Cells]., PMID:32131936

Cetuximab enhances the efficiency of irinotecan through simultaneously inhibiting the MAPK signaling and ABCG2 in colorectal cancer cells., PMID:31889589

Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states., PMID:30405239

Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo., PMID:30391357

Synthesis and biological evaluation of quinazoline derivatives - A SAR study of novel inhibitors of ABCG2., PMID:30390439

Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys., PMID:30351177

Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells., PMID:30315846

2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2., PMID:30075623

Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters., PMID:29670629

New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold., PMID:29547272

Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study., PMID:29509884

Broad blocking of MDR efflux pumps by acetylshikonin and acetoxyisovalerylshikonin to generate hypersensitive phenotype of malignant carcinoma cells., PMID:29472576

Human aniridia limbal epithelial cells lack expression of keratins K3 and K12., PMID:29162348

ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells., PMID:29079042

Structure of the human multidrug transporter ABCG2., PMID:28554189

Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters., PMID:28493713

Circulating intestine-derived exosomal miR-328 in plasma, a possible biomarker for estimating BCRP function in the human intestines., PMID:27571936

An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter., PMID:27488911

Antibody validation and scoring guidelines for ABCG2 immunohistochemical staining in formalin-fixed paraffin-embedded colon cancer tissue., PMID:27257141

FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells., PMID:26654944

Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model., PMID:26314844

Suspected anemia caused by maternal anti-Jra antibodies: a case report., PMID:26301094

Inhibitory effect of epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2 antibody combined with therapeutic ultrasound on multiple myeloma cancer stem cells., PMID:26204324

Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives., PMID:26197160

Quantum dot labeling and tracking of cultured limbal epithelial cell transplants in vitro., PMID:26024089

Endocytosis of ABCG2 drug transporter caused by binding of 5D3 antibody: trafficking mechanisms and intracellular fate., PMID:25918011

Breast cancer resistance protein identifies clonogenic keratinocytes in human interfollicular epidermis., PMID:25881149

Comparison of Explant and Enzyme Digestion Methods for Ex Vivo Isolation of Limbal Epithelial Progenitor Cells., PMID:25860821

Safety profile of accelerated corneal cross-linking versus conventional cross-linking: a comparative study on ex vivo-cultured limbal epithelial cells., PMID:25488945

ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer., PMID:25427584

PTEN loss-mediated Akt activation increases the properties of cancer stem-like cell populations in prostate cancer., PMID:25139413

ABCG2 is a selectable marker for enhanced multilineage differentiation potential in periodontal ligament stem cells., PMID:25101689

Immunolocalization of ABC drug transporters in human placenta from normal and gestational diabetic pregnancies., PMID:25029804

Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1., PMID:24937702

WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells., PMID:24903205

Gamma-Fe2O3 nanoparticles increase therapeutic efficacy of combination with paclitaxel and anti-ABCG2 monoclonal antibody on multiple myeloma cancer stem cells in mouse model., PMID:24738341

Datasheet
$ 225
Product specifications
50 μg 225 100 μg 372

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human CD338/ABCG2 Antibody (5D3) [FHJ82310]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only